Clinical Professor of Experimental Cancer Medicine, Northern Institute for Cancer Research, Newcastle University
Ruth Plummer is Professor of Experimental Cancer Medicine at the Northern Institute for Cancer Research, Newcastle University and an honorary consultant medical oncologist in Newcastle Hospitals Foundation Trust. She is Director of the Sir Bobby Robson Cancer Trials Research Centre within the Northern Centre for Cancer Care which is a dedicated clinical trials unit based within the regional cancer centre. She leads the Newcastle Experimental Cancer Medicine Centre and also the CRUK Newcastle Cancer Centre. She trained at Cambridge and Oxford before moving back home to Newcastle and settling with her family in the Tyne valley.
Her research interests are in the field of DNA repair and early phase clinical trials of novel agents or novel imaging targets. She developed the clinical pharmacodynamic assay used in the first-in-class PARP inhibitor trial in 2003, and has worked with many of the PARP inhibitors currently under clinical development. Her pre-clinical research